| Literature DB >> 30738992 |
Gi-Sang Bae1, Dong-Goo Kim2, Il-Joo Jo3, Sun-Bok Choi1, Myoung-Jin Kim4, Joon Yeon Shin4, Dong-Uk Kim4, Ho-Joon Song4, Myungsoo Joo5, Sung-Joo Park6.
Abstract
Heme oxygenase-1 (HO-1) has an anti-inflammatory action in acute pancreatitis (AP). However, its mechanism of action and natural compounds/drugs to induce HO-1 in pancreas are not well understood. In this study, we investigated the regulatory mechanisms of HO-1 during AP using desoxo-narchinol-A (DN), the natural compound inducing HO-1 in the pancreas. Female C57/BL6 Mice were intraperitoneally injected with supramaximal concentrations of cerulein (50 μg/kg) hourly for 6 h to induce AP. DMSO or DN was administered intraperitoneally, then mice were sacrificed 6 h after the final cerulein injection. Administration of DN increased pancreatic HO-1 expression through activation of activating protein-1, mediated by mitogen-activated protein kinases. Furthermore, DN treatment reduced the pancreatic weight-to-body weight ratio as well as production of digestive enzymes and pro-inflammatory cytokines. Inhibition of HO-1 by tin protoporphyrin IX abolished the protective effects of DN on pancreatic damage. Additionally, DN treatment inhibited neutrophil infiltration into the pancreas via regulation of chemokine (C-X-C motif) ligand 2 (CXCL2) by HO-1. Our results suggest that DN is an effective inducer of HO-1 in the pancreas, and that HO-1 regulates neutrophil infiltration in AP via CXCL2 inhibition.Entities:
Keywords: Acute pancreatitis; Chemokine (C-X-C motif) ligand 2; Desoxo-narchinol-A; Heme oxygenase-1; Neutrophils
Mesh:
Substances:
Year: 2019 PMID: 30738992 DOI: 10.1016/j.intimp.2019.01.051
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932